Hege Garelius

Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: <scp>A</scp> report from the <scp>S</scp>wedish <scp>A</scp>cute <scp>L</scp>eukemia <scp>R</scp>egistry

Erik Hulegårdh, Christer Nilsson, Vladimir Lazarević et al. · American Journal of Hematology · 2014 · 278 citations · Full text

Medicine, Hematology, Oncology +13

Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

Herman Nilsson‐Ehle, Gunnar Birgegård, Jan Samuelsson et al. · European Journal Of Haematology · 2011 · 63 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013

Sören Lehmann, Stefan Deneberg, P Antunović et al. · Leukemia · 2017 · 63 citations

Medicine, Oncology, Cancer Epidemiology +11

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Christer Nilsson, Fredrika Linde, Erik Hulegårdh et al. · Haematologica · 2022 · 58 citations · Full text

Medicine, Hematology, Oncology +11

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial

Magnus Tobiasson, I Dybedahl, Mette Skov Holm et al. · Blood Cancer Journal · 2014 · 55 citations · Full text

Medicine, Hematology, Pharmacology +17